Abstract
A clinical decision report using: del Amo J, Polo R, Moreno S, et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy. Annals of Internal Medicine. 2020;173(7):536-541. https://doi.org/10.7326/m20-3689 for a patient with HIV and concerns about COVID-19 for immunocompromised individuals.
Highlights
Follow this and additional works at: https://digitalcommons.wayne.edu/crp Part of the Infectious Disease Commons, Medical Education Commons, Medical Pharmacology
This Clinical Decision Report is brought to you for free and open access by the Open Access Journals at DigitalCommons@WayneState. It has been accepted for inclusion in Clinical Research in Practice: The Journal of Team Hippocrates by an authorized editor of DigitalCommons@WayneState
Cover Page Footnote I would like to thank Dr Norman Markowitz for productive discussions and mentorship throughout the entire writing process. This clinical decision report is available in Clinical Research in Practice: The Journal of Team Hippocrates: https://digitalcommons.wayne.edu/crp/vol7/iss2/1
Summary
For a 57-year-old male person living with HIV (PLWH) receiving Biktarvy® and living in an urban center in the Midwestern US, is the risk of acquiring COVID-19 infection different from a seronegative person of the general population?. Research Article del Amo J, Polo R, Moreno S, et al Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical Research In Practice: The Journal of Team Hippocrates
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
